ConductScience.org, home

Paper319356

A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.

McCallum RW and 3 others. N Engl J Med, 1977. Cited by 137 papers, by iCite.

Cite this record

ConductScience Library. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. Papers, record 319356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/319356

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.
PubMed
Journal
N Engl J Med
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
137
iCite
Relative citation ratio, by iCite
7.08
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McCallum RWR W
2Ippoliti AFA F
3Cooney CC
4Sturdevant RAR A

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastroesophageal RefluxMajor topic
MetoclopramideMajor topic
Antacids
Anxiety
Chronic Disease
Clinical Trials as Topic
Esophagus
Female
Gynecomastia
Heartburn
Humans
Male
Middle Aged
Placebos
Pressure

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.

PMIDTitleJournalYearIn PapersSource
39282236GERD: Latest update on acid-suppressant drugs.Curr Res Pharmacol Drug Discov2024https://conductscience.org/library/papers/39282236PubMed
23728637Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23728637PubMed
21278804Metoclopramide in the treatment of diabetic gastroparesis.Expert Rev Endocrinol Metab2010https://conductscience.org/library/papers/21278804PubMed
12509687A rational approach to uninvestigated dyspepsia in primary care: review of the literature.Postgrad Med J2002https://conductscience.org/library/papers/12509687PubMed
8934580Risks and benefits of drugs used in the management of postoperative nausea and vomiting.Drug Saf1996https://conductscience.org/library/papers/8934580PubMed
7286058Single-dose pharmacokinetics of metoclopramide.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7286058PubMed
7067581When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment.Dig Dis Sci1982https://conductscience.org/library/papers/7067581PubMed
7014172Current approaches in the medical treatment of oesophageal reflux.Drugs1981https://conductscience.org/library/papers/7014172PubMed
6360597Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients.Dig Dis Sci1983https://conductscience.org/library/papers/6360597PubMed
6345129Metoclopramide. An updated review of its pharmacological properties and clinical use.Drugs1983https://conductscience.org/library/papers/6345129PubMed
6345111Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.Dig Dis Sci1983https://conductscience.org/library/papers/6345111PubMed
3965270Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis.Dig Dis Sci1985https://conductscience.org/library/papers/3965270PubMed
3691273Effect of cisapride, a new prokinetic agent, on esophageal motor function.Dig Dis Sci1987https://conductscience.org/library/papers/3691273PubMed
3294124Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.Gut1988https://conductscience.org/library/papers/3294124PubMed
3282846Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.Dig Dis Sci1988https://conductscience.org/library/papers/3282846PubMed
1551349Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study.Dig Dis Sci1992https://conductscience.org/library/papers/1551349PubMed
732429[Indication for conservative therapy of reflux esophagitis (author's transl)].Langenbecks Arch Chir1978https://conductscience.org/library/papers/732429PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/319356

GET https://conductscience.org/api/papers/v1/319356/authors